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This paper proposes several hypotheses and research strategies for exploring possible
psychological factors contributing to multiple chemical sensitivity (MCS). The hypotheses are based
on concepts of individual response stereotypy, situational response specificity, classical conditioning
of chemical-induced responses, and psychophysiological reactions to active and passive coping
orientations. Hypotheses regarding hypersensitivity to perception and/or aversiveness of
chemical stimulation also are presented. Strategies for evaluating these hypotheses are
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Introduction
The topic of psychological aspects of
multiple chemical sensitivity syndrome
(MCS) raises some political issues, particu-
larlywith individuals who have the disorder
and resent being treated as ifthe problem
were imaginary. Therefore, before the
topic can be addressed scientifically, some
justification sensitive to these concerns
must be made for undertaking this avenue
ofinvestigation. I propose the following.
First, conducting research on possible
psychological or psychophysiological con-
tributions to MCS does not imply that
MCS is entirely or primarily psychological.
Scientific investigation is neutral on the
topic. Ifpsychological factors play no role
or a minimal role in MCS, a program of
good research will be able to establish this
firmly. Ifpsychological factors do play a
part, then understanding them can only
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help in the prevention and treatment of
this debilitating problem.
Second, ifpsychological factors are found
to play an important role in MCS, this does
not necessarily imply that the problem is
imaginary. The distinction between psycho-
logical and somatic disorders has become
blurred in recent years. It is well known
that psychological factors can exacerbate a
variety of somatic diseases, including
headache (1-3), ischemic heart disease (4),
cancer (5,6), Raynaud's disease (7),
rheumatoid arthritis (8), asthma (9), irrita-
ble bowel syndrome (10), chronic pain
(11), and even some infectious diseases
(12). The role ofpsychological factors in
exacerbation of these diseases has been
firmlyestablished. Some evidence also exists
for a possible contributing role in diathesis.
Conversely, some psychological disorders
are known to be triggered by physical ail-
ments that produce similar symptoms. For
example, panic disorder and other anxiety
disorders have a statistical relationship with
the presence ofsuch disorders as mitral valve
prolapse (13), hyperthyroidism (14), irrita-
ble bowel syndrome (15,16), and asthma
(17,18). Although no firm evidence exists
regarding the direction ofcausality, several
theories have been proposed implicating
these physical disorders as causal factors in
panic disorder. Also, psychological disorders
including anxiety and depression have been
linked to particularkinds ofbrain pathology,
such as depressed levels of serotonin and
various structural abnormalities (19,20). So
even some purely psychological disorders
have physiological bases. Ifa chemical expo-
sure adversely affects the central nervous sys-
tem, some ofthe resulting symptoms may
looklike mental disorders.
Third, finding an important role for
psychological procedures in treating MCS
does not necessarily exclude the possibility
that the disorder is organic in origin. This
is true even if these psychological proce-
dures are as effective or more effective than
various medical interventions. For exam-
ple, this is the case for muscle contraction
(21) and migraine headaches (22,23), irrita-
ble bowel syndrome (24,25), and Raynaud's
disease (26). Psychological components in
treatment programs have proven effective
for hypertension (27), cancer (28,29), and
epilepsy (30), to name a few. Ifexposure to
chemicals is a psychological stressor among
MCS patients (probably in addition to
being a physical trigger of symptoms), a
stress-related autonomic reaction also may
occur, perhaps superimposed on other
physical reactions.
This paper reviews some of the psy-
chophysiological research paradigms that
have been used to describe human psy-
chophysiological response to various kinds
of stimulation. Ifneuropsychological fac-
tors play any role in MCS, their influence
may be measured by research using some
ofthese paradigms.
Psychophysiological Concepts
As Applied to MCS
Indiidual ResponseStereotypy
Research from the 1950s to the 1970s
shows that some individuals tend to pro-
duce highly specific physiological responses
to many stressors whereas others apparently
do not. This tendency has been called indi-
vidual response stereotypy (31). Thus, some
people respond primarily with heart rate
(HR) variability, or just with skin conduc-
tance responses, to avariety ofpsychological
challenges, from mental arithmetic to scary
movies to reaction time tasks. Individuals
who respond in one physiological system
may not respond in another.
Not everyone shows individual response
stereotypy, but some do to a marked extent.
It has been hypothesized that in some cases
stereotypy may predispose an individual to
psychosomatic disease (32). Consistent
with this, individuals with family histories
ofhypertension (and who therefore may
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have a physiological predisposition to
hypertension) tend to show greater cardio-
vascular reactivity to a variety oflaboratory
stressors (33). Similarly, asthmatics have
been found to react to a variety ofstressors
with bronchoconstriction (34) and muscle
contraction headache patients react with
tension in the skeletal muscles ofthe face
and shoulders, etc. (35). It is possible that
severe chemical exposure may act as an
unconditional stimulus, producing one-trial
learning ofa conditioned neuropsychologi-
cal response. It may have a particular sensi-
tizing effect upon individuals who are
predisposed to stereotypic psychophysio-
logical responsiveness (e.g., in the lung or
the nose) even before exposure. Later this
same physiological response may generalize
and be elicited by other substances. In this
stage it may also be elicited in response to
psychological stressors.
In some people response to chemical
exposure may be in the cardiovascular sys-
tem (palpitations, faintness), in some cases
in the respiratory system (wheezing or
mucous secretions), and in some cases
such chemical exposure may cause nausea,
inflammation, fever, fatigue, muscular
aches and pains, weakness, or perhaps psy-
chological symptoms such as confusion,
anxiety, or depression. After chemical expo-
sure, it is possible that the body's self-regu-
latory system is compromised, so exposure
to various kinds ofstressors, particularly
chemical ones, produces a stereotyped
physiological stress response in this subpop-
ulation. To the extent that this response
may be mediated in part by the central ner-
vous system(CNS), psychological factors
may be involved.
Situatonal ResponseSpecificity
Some tasks elicit characteristic physiological
responses (31). For example, tasks eliciting
an attitude ofactive coping tend to produce
a particular response characterized by beta
sympathetic activation: increased heart rate
and systolic blood pressure, bronchodila-
tion, and increased ventilation (36-39).
Aversive tasks associated with a more passive
response (e.g., watching ascaryfilm) tend to
elicit responses such as alpha sympathetic
activation (peripheral vasoconstriction),
increased cardiotropic parasympathetic
activity, andbronchoconstriction (40-42).
Ifexposure to chemicals is a psychologi-
cal stressor among MCS patients (in addi-
tion to possibly being a physical trigger of
symptoms), a stress-related autonomic reac-
tion also may occur, perhaps superimposed
on other physical reactions. If exposure
cannot be avoided, we might expect the
psychological component ofthe response
to be similar to the passive coping profile:
faintness, increasedvagal tone, and asthma-
like symptoms. On the other hand, ifthe
individual finds the exposure situation
aversive and can avoid it, the response may
include rapid heartbeat and perhaps palpi-
tations, bronchodilation, and increased
ventilation. These all are common symp-
toms in MCS. According to this theory,
however, ifthe situation is not perceived to
be aversive, no observable autonomic
response is expected except that directly
produced by the chemical (which should
be observable in people without MCS and
in lower animals).
There is also evidence that exposure to
stimuli previously associated with chemical
exposure can produce a strong conditioned
psychophysiologial response specific to
the particular chemical (43). Siegel has
hypothesized that this response is adaptive
in that it may prepare the body for dealing
with oncoming chemical exposure more
effectively (43). Thus, as observed in
everyday situations, the sight and smell of
food elicits various changes in the gastroin-
testinal tract. Aromas, sights, and sounds
associated with a particular place immedi-
ately elicit thoughts and often feelings and
desires. Perfume elicits such powerful emo-
tional responses that major industries have
been capitalizing for centuries on pro-
nounced psychophysiologial effects of
chemicals in the air. It is possible that
through psychological conditioning such
exposures might also elicit physiological
reactions that could explain at least some of
the symptoms ofMCS.
Some specific symptoms ofdisease can
even be triggered by suggestion. In the
asthma literature a number ofstudies have
provided evidence that psychogenic asthma
attacks can occur even when a person sim-
ply thinks that exposure to an asthma trig-
ger has occurred. The typical experimental
paradigm here involves telling the asth-
matic subject that (s)he is being exposed to
an asthma trigger (an allergen or a bron-
choconstrictor), and then subjecting the
person to a convincing exposure ofan inert
substance (e.g., nebulized saline or just
room air); the subject believes that (s)he
has been exposed to a nebulized bron-
choconstrictor. Among some asthmatics
(between 1 in 4 and 1 in 20, depending on
the study), a clinically significant broncho-
constriction occurs (34). Similarly, bron-
chodilation may occur in some subjects
when they believe they are being exposed
to a bronchodilator (44). Clinically signi-
ficant bronchoconstriction responses tend
not to occur in nonasthmatics, although
briefand small but statistically significant
responses sometimes occur in this group
as well. (45).
RelationshipbetweenIndividual
ResponseStereotypy, Stimulus
ResponseSpecificity, and
PsychosomaticDisease
It is possible that psychosomatic disease
may occur when a person with a tendency
toward individual response stereotypy is
repeatedly exposed over long periods of
time to situations that also specifically
evoke that person's characteristic response.
Under such circumstances, the body may
change its homeostatic set point, or it may
continually return to a level ofphysiologi-
cal arousal that may be maladaptive in
other respects. Alternatively, the organism
may become overly sensitized to particular
types of stimulation and thus may over-
react to stimulation that ordinarily would
evoke no response. Such sensitization may
occur either after repetitive stimulation or
even after a single mass exposure, as in
traumatic conditioning, particularly where
the organism is preprogrammed to develop
such a response. The concept ofbiological
prepotency or preparedness has been used
to describe the tendency for certain biolog-
ically relevant stimuli to be more powerful
than others as nonhabituating and/or con-
ditional stimuli (46). Although biological
prepotency does not explain much variance
in development ofhuman phobias, as orig-
inally hypothesized (47) it is possible that
certain types ofchemical stimulation may
be found to be prepotent in this way. Thus,
we might hypothesize that MCS patients,
whose systems are highly attuned to cues of
chemical exposure, show a similar psy-
chophysiologial sensitization to olfactory
cues ofchemical exposure after repeated or
traumatic exposure. The critical factor dis-
tinguishing such reactions from nonpsy-
chological sensitization reactions (e.g., as
may occur in allergies) is the role of the
central nervous system and psychological
experience in producing the effects.
Eflf s ofCognitiveStyle
Research on coping with stress suggests
that the cognitive orientation ofthe indi-
vidual toward stressful stimulation has a
measurable and reliable effect on physio-
logical response (48). It is reasonable,
therefore, to hypothesize that this is also
true when stimulation is in the form of
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aversive chemical exposure. Some individuals
may interpret chemical exposure as aver-
sive, unavoidable, and inescapable, and
thus exhibit a passive coping response. In
such cases, symptoms offaintness and dys-
pnea may prevail because ofincreased vagal
tone and bronchoconstriction. Others may
experience palpitations and discomfort
associated with muscle tension, because
they experience the stimulation as a "call to
action." Still others may not consider expo-
sure aversive, and so exhibit no emotionally
induced physiological response.
Differences in Perceptual
Sensitivityfor Olfactory
Stimulation
Because the presence and severity ofMCS
are determined primarily by self-reporting
of symptoms, it is possible that sensitivity
and ability (or willingness) to report
unpleasant sensations are important com-
ponents ofthe clinical presentation ofthe
disease. Therefore it is important to study
the sensitivity of MCS patients to various
kinds ofbody stimulation and compare it
to the sensitivity ofindividuals without this
problem. Greater perceptual sensitivity to
the magnitude or aversiveness ofchemical
stimulation would be consistent with the
possibility that MCS is mediated, in part,
by psychophysiologial processes, although
this would not prove definitively that such
processes have a causal role. The keenness
ofperception ofolfactory stimulation may
be a particularly important variable. This
may be measurable using any of several
paradigms in psychophysics (49).
MgnitudeEstimaton
Magnitude estimation would involve
exposing MCS patients to various quanti-
ties ofinhaled chemicals and then asking
them to rate the relative magnitude ofthe
exposures. This can be done by asking
patients to give a number proportional to
the amount ofexposure relative to a stan-
dard stimulus ofexposure. The usual metric
associated with this method is the slope of
the gain in perception ofintensity relative
to the gain in actual exposure. Individuals
who are more sensitive to stimulation
would have higher slopes, usually after data
are converted to a log-log function, to
account for the expected curviinearity in all
modes ofperception.
In addition, the aversiveness associated
with exposure can be quantified. Based on
previous research on pain and on asthma, it
would be useful to measure relevant dimen-
sions of the chemical-induced symptoms.
It is known that most physical symptoms
have two independent dimensions: inten-
sity and unpleasantness. Of these, the
intensity dimension tends to be more
closely related to physical intensity ofstim-
ulation, whereas unpleasantness is related to
the subject's emotional reaction to the stim-
ulation. These two dimensions have been
documented in laboratory studies ofexperi-
mentally induced pain (50) and dyspnea
(51). Tursky et al. (50) developed the Pain
Perception Profile, a verbal rating scale for
psychophysical estimate ofpain. We have
adapted it for assessment of dyspnea in
asthma (51). IfMCS individuals experi-
ence greater discomfort than others but
similar levels of perception, this provides
some evidence that central nervous system
centers involving emotional reactivity (e.g.,
limbic centers) are sensitized in this popu-
lation or perhaps that endorphin levels,
which may mitigate feelings ofdiscomfort,
are particularly low in this population. If
sensitivity to the magnitude ofthe stimula-
tion is elevated among MCS patients, it is
possible that sensory nerves and reflexes
associated with sensation may be more
active among MCS patients. Data from
our laboratory suggest that psychological
factors may have a greater impact on per-
ception ofthe unpleasantness ofa stimula-
tion than in perception ofthe magnitude
or intensity ofthe stimulus (52).
ThresholdDetection
Another method for quantifying perceptual
sensitivity to stimulation is threshold
detection. In this procedure the intensity
of exposure in gradually increased to the
point at which the individual first feels
something. This point is the threshold of
detection. Threshold detection studies also
can determine the threshold for detecting a
"just noticeable difference" in exposure. If
MCS patients have lower absolute and dif-
ference thresholds than other subjects, it is
possible that they are more tuned to react-
ing to this type ofstimulation. Differences
in sensitivity may reflect either physiologi-
cal processes (e.g., greater sensory receptor
sensitivity) or psychological processes (e.g.,
greater alertness to chemical stimulation).
Asingle study by Doty et al. (53) found no
differences between MCS patients and
normal individuals in the threshold for
detecting the odor ofphenyl ethyl alcohol
and methyl ethyl ketone, but throughout
the testing session MCS patients were
found to have higher nasal resistances, res-
piration rates, and Beck Depression inven-
tory scores. These data suggest that MCS
patients may not be perceptually more
sensitive to odors than other subjects, but
they generally exhibit greater depression
and decreased nasal patency.
MethodofProduction
Instead ofresponding verbally in threshold
detection tasks, individuals can self-admin-
ister stimulation and stop the stimulation
when they have reached a threshold of
detection. This method can be used in
conjunction with the magnitude estima-
tion method; i.e., subjects can estimate the
magnitude ofdiscomfort. In one study, our
laboratory used this method with patients
suffering from muscle contraction head-
aches (54). A tourniquet was tied around
their upper arms and subjects were asked
to pump a ball until they began to feel dis-
comfort, then pain, then pain sufficient to
make them want to stop pumping. (To
prevent subjects from harming themselves
they were not permitted to do this task for
more than 1.5 min.) We found that head-
ache patients detected discomfort and pain
within shorter time periods than other sub-
jects but reported the pain to be more
intense than did the other subjects. This
suggested that headache pain patients were
more sensitive than others to forms of
ischemic pain in areas other than the head.
Hyperventilation as a Possible
Intervening Variable in MCS
Many physical and emotional stressors
produce hyperventilation, as do some dis-
ease states involving pulmonary or renal
dysfunction. Symptoms ofhyperventila-
tion are extraordinarily varied, and can
include some common symptoms ofMCS.
They can include headache, dyspnea, pal-
pitations, tremor, pain, panic, and even
seizure activity (55). It would therefore be
of interest to study the occurrence of
hyperventilation in this population, partic-
ularly in response to chemical stimulation.
If hyperventilation plays a role in MCS,
then the respiratory responses ofMCS vic-
tims may be expected to differ from those
ofnormal subjects and may be more simi-
lar to those among people with known res-
piratory abnormalities or panic disorder,
both ofwhich produce measurable effects
on respiratory response to stress.
A tendency to hyperventilate can be
measured noninvasively by measuring end-
tidal C02, via a small tube placed at the
end of the nostril. A decrease in petCO2
might be expected after chemical exposure
among individuals who hyperventilate and
may indicate an emotional response to
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such stimulation. Although the existence of
such a response would not indicate that the
symptoms ofMCS are necessarily caused by
a hyperventilation response (because corre-
lation cannot prove causation), lack ofcor-
relation could rule out stimulus-induced
hyperventilation as a mediating variable
in MCS.
In addition to petCO2, other respiratory
measures may provide useful information.
Measures of respiratory resistance can
assess responses involving bronchodilation
or bronchoconstriction. Bronchodilation
may predispose a person to hyperventilate,
whereas bronchoconstriction may produce
some asthmalike symptoms. IfMCS patients
react bronchially more to psychological
stress than other individuals, it is possible
that this response may contribute to some
ofthe symptoms ofMCS.
Assessing respiratory drive after exposure
to various chemical stressors also would
assess the possibility of an augmented
respiratory response. Asthmatics tend to
show a greater increase in inspiratory effort
in response to breathing through external
resistors than do other individuals, and
panic disorder patients show greater inspi-
ratory pressure responses in response to
breathing CO2. If MCS patients show
greater increases in respiratory drive than
others when exposed to noxious chemicals,
this would also suggest that some symptoms
ofMCS may result from hyperventilation.
Conclusion
This paper has presented some paradigms
that have proven useful in the field ofpsy-
chophysiology, and which have shed some
light on asthma and panic disorder. Similar
research also has revealed information
about the contribution of psychological
factors to hypertension and cardiovascular
disease as well as to a host of other ail-
ments. Finding an association between
MCS and psychophysiologial responsivity
does not necessarily prove a relationship,
but it may produce useful information
about the mechanisms ofMCS that could
prove important in finding treatments for
the disorder. For example, ifhyperventila-
tion were associated with MCS, then
breathing retraining programs may be
helpful. Ifheightened perceptual sensitivity
is involved, desensitization paradigms may
be helpful. Ifdifferences in interpretation
ofphysical stimulation are involved, cogni-
tive therapy may play a role, as may some
antianxiety medication. If a passive coping
orientation is implicated, alternative strate-
gies might be explored that involve helping
individuals develop more active strategies
to cope with various physical and emo-
tional stressors. Psychophysiologial investi-
gation ofMCS, therefore, holds promise of
detecting factors that may help in psycho-
logical control symptoms and consequent
reduction in disability.
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